![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Valsartan, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2013-095 - Rev 00
This Chemical Type CEP, issued on September 04, 2014, remains in force until April 03, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes